GENEVA, March 31 -- TRIMT GMBH (Carl-Eschebach-Str. 701454 Radeberg) filed a patent application (PCT/EP2024/076472) for "FUNCTIONALIZED PEPTIDES FOR IN-VIVO ADDRESSING OF PD-L1 EXPRESSION" on Sep 20, 2024. With publication no. WO/2025/061971, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NOTNI, Johannes (Mettberg 40b45549 Sprockhovel)

Abstract: The present invention provides conjugate compounds as well as radiotracers and radiopharmaceuticals comprising the same as well as their use in the imaging of PD-L1 expression...